Hepion Pharmaceuticals, Inc.
HEPA
$0.06
$0.000.00%
OTC PK
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 19.48% | 15.50% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 30.97% | 15.50% | |||
| Operating Income | -30.97% | -15.50% | |||
| Income Before Tax | -23.43% | -39.03% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -23.43% | -39.03% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -23.43% | -39.03% | |||
| EBIT | -30.97% | -15.50% | |||
| EBITDA | -- | -15.72% | |||
| EPS Basic | -23.98% | -38.33% | |||
| Normalized Basic EPS | -30.93% | -18.93% | |||
| EPS Diluted | -24.33% | -38.33% | |||
| Normalized Diluted EPS | -30.93% | -18.93% | |||
| Average Basic Shares Outstanding | -0.49% | 0.49% | |||
| Average Diluted Shares Outstanding | -0.49% | 0.49% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||